Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Horizon Therapeutics plc

https://www.horizontherapeutics.com

Latest From Horizon Therapeutics plc

FTC Is Taking A Tougher Stance On Pharma, A Deputy Director Explains Why

Rahul Rao, the deputy director of the FTC Bureau of Competition, discussed the agency’s thinking on recent pharma deals that it viewed as anti-competitive.

Deals Enforcement

FTC Is Taking A Tougher Stance On Pharma; A Deputy Director Explains Why

Deputy director of the Bureau of Competition Rahul Rao discussed the agency’s thinking on recent pharma deals that it viewed as anti-competitive.

Deals Enforcement

Zenas Raises $200m For Bifunctional Antibody In Autoimmune Diseases

Zenas BioPharma plans to have data from four trials – two under way and two starting this summer – for obexelimab, which targets CD19 and FcγRIIb, within about a year and a half.

Financing Immune Disorders

Amgen Planning Pivotal Obesity Program For MariTide

Executives said during Amgen’s Q1 call that the company is “encouraged” by interim Phase II data for MariTide (AMG 133) in obesity, so it is designing Phase III trials and building manufacturing capacity. 

Metabolic Disorders Strategy
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • Bio-Technology General Corporation
    • Crealta Holdings LLC
    • Crealta Pharmaceuticals
    • Curzion Pharmaceuticals, Inc.
    • Encode Pharmaceuticals, Inc.
    • Horizon Pharma plc
    • Hyperion Therapeutics, Inc. (Andromeda Biotech Ltd)
    • Nitec Pharma AG
    • Raptor Pharmaceutical Corp.
    • River Vision Development Corp.
    • Savient Pharmaceuticals, Inc. (SVNT)
    • TorreyPines Therapeutics, Inc. (Neurogenetics Inc.)
    • Vidara Therapeutics Inc
    • Viela Bio, Inc.
UsernamePublicRestriction

Register